↓ Skip to main content

Human pancreatic adenocarcinoma contains a side population resistant to gemcitabine

Overview of attention for article published in BMC Cancer, August 2012
Altmetric Badge

Citations

dimensions_citation
51 Dimensions

Readers on

mendeley
44 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
Human pancreatic adenocarcinoma contains a side population resistant to gemcitabine
Published in
BMC Cancer, August 2012
DOI 10.1186/1471-2407-12-354
Pubmed ID
Authors

Anke Van den broeck, Lies Gremeaux, Baki Topal, Hugo Vankelecom

Abstract

Therapy resistance remains one of the major challenges to improve the prognosis of patients with pancreatic cancer. Chemoresistant cells, which potentially also display cancer stem cell (CSC) characteristics, can be isolated using the side population (SP) technique. Our aim was to search for a SP in human pancreatic ductal adenocarcinoma (PDAC) and to examine its chemoresistance and CSC(-like) phenotype.

Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 44 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
United States 1 2%
France 1 2%
Australia 1 2%
Unknown 41 93%

Demographic breakdown

Readers by professional status Count As %
Student > Ph. D. Student 10 23%
Researcher 8 18%
Student > Master 7 16%
Professor 4 9%
Other 3 7%
Other 7 16%
Unknown 5 11%
Readers by discipline Count As %
Agricultural and Biological Sciences 11 25%
Medicine and Dentistry 10 23%
Biochemistry, Genetics and Molecular Biology 6 14%
Pharmacology, Toxicology and Pharmaceutical Science 3 7%
Engineering 3 7%
Other 4 9%
Unknown 7 16%